Accardi Mario Alberto — SEC Form 4 filings
SEC reporting owner CIK 2074392. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2025-06-25 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 7 filings — 66,494 shares, $1,439,886 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 10,000 shares @ $30.00 ($300,000) in Centessa Pharmaceuticals plc, filed 2025-12-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer, Director | 12 | — | 9 legs · 66,494 sh · $1,439,886 | 21 |
Form 4 filings — Accardi Mario Alberto
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-24 | 4 | Centessa Pharmaceuticals plc (CNTA) | Disposition to issuer (D): 243,282 · Disposition to issuer (D): 6,250 (derivative) · Disposition to issuer (D): 16,875 (derivative) · Disposition to issuer (D): 15,300 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 225,000 (derivative) · +1 more | EDGAR |
| 2026-05-18 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 604 @ $39.42 | EDGAR |
| 2026-02-03 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 2,915 @ $24.57 · Grant/award (A): 68,000 @ $0 · Grant/award (A): 273,000 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 7,432 @ $28.70 · Sale (S): 2,568 @ $29.21 | EDGAR |
| 2025-12-08 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 5,000 @ $9.53 · Sale (S): 10,000 @ $30 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-11-03 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 593 @ $24.90 | EDGAR |
| 2025-10-27 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 5,000 @ $8.01 · Sale (S): 8,000 @ $25 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-09-16 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 7,430 @ $21.33 · Sale (S): 742 @ $22.02 | EDGAR |
| 2025-09-11 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 5,000 @ $8.01 · Sale (S): 7,000 @ $20 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-08-01 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 597 @ $17.17 | EDGAR |
| 2025-07-30 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 8,322 @ $15.23 | EDGAR |
| 2025-06-25 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 15,000 @ $3.85 · Sale (S): 15,000 @ $14 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2074392 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →